Ispaghula and Levothyroxine sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ispaghula (blond psyllium) and Levothyroxine sodium (levothyroxine sodium). Common drug interactions include balance disorder among females and depressed mood among males.

The phase IV clinical study analyzes what interactions people have when they take Ispaghula and Levothyroxine sodium. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Ispaghula?

Ispaghula has active ingredients of blond psyllium. eHealthMe is studying from 737 Ispaghula users. Check the latest studies of Ispaghula.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,812 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.



On Jul, 20, 2026

40 people who take Ispaghula and Levothyroxine sodium together, and have interactions are studied.

Ispaghula and Levothyroxine sodium drug interactions.

What are the common drug interactions of Ispaghula and Levothyroxine Sodium, by gender? *:

female:

  1. Balance disorder
  2. Blood calcium decreased
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Constipation
  5. Creatinine renal clearance decreased
  6. Depressed level of consciousness
  7. Fall
  8. Hypotension (abnormally low blood pressure)
  9. Mobility decreased (ability to move is reduced)
  10. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

male:

  1. Depressed mood
  2. Restlessness (not able to rest)
  3. Gout (uric acid crystals building up in the body)
  4. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  5. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Restless legs syndrome (a powerful urge to move your legs)
  8. Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp)
  9. Abdominal pain
  10. Constipation

What are the common drug interactions of Ispaghula and Levothyroxine Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Depressed mood
  2. Drug ineffective

50-59:

  1. Abdominal pain
  2. Constipation
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Gout (uric acid crystals building up in the body)
  7. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  8. Oedema peripheral (superficial swelling)
  9. Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp)

60+:

  1. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  2. Balance disorder
  3. Sedation
  4. Pain
  5. Restlessness (not able to rest)
  6. Chest discomfort
  7. Dizziness
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Drug abuse
  10. Hyponatraemic syndrome (serum sodium concentration below 135 mmol/l)

What are the existing conditions these people have? *

  1. Constipation: 18 people, 45.00%
  2. Stable Angina (a constant chest pain): 17 people, 42.50%
  3. Insomnia (sleeplessness): 17 people, 42.50%
  4. High Blood Pressure: 17 people, 42.50%
  5. Urinary Tract Infection: 16 people, 40.00%
  6. Thyroid Diseases: 16 people, 40.00%
  7. Bladder Disorder: 16 people, 40.00%
  8. Chest Pain: 16 people, 40.00%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 16 people, 40.00%
  10. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 16 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ispaghula and Levothyroxine sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ispaghula and Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ispaghula:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ispaghula and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothyroxine sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on blond psyllium and levothyroxine sodium (the active ingredients of Ispaghula and Levothyroxine sodium, respectively), and Ispaghula and Levothyroxine sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: